
欧洲止血分析仪市场预测至 2028 年 - 按产品类型(实验室分析仪 [自动化系统、半自动化系统和手动系统])和护理点测试系统)、测试(激活部分凝血活酶时间、D-二聚体测试、纤维蛋白原测试、凝血酶原时间 (PT) 测试等)和最终用户(医院/诊所、独立诊断实验室、家庭护理机构等)
No. of Pages: 135 | Report Code: TIPRE00027180 | Category: Life Sciences
No. of Pages: 135 | Report Code: TIPRE00027180 | Category: Life Sciences
市场介绍
止血分析仪是测量止血凝血机制的设备,以检测凝血缺陷并促进医生对出血过多患者的治疗。不断的技术进步使得随着许多创新药物和高性能止血分析仪等仪器的推出,预计将推动止血分析仪的需求增长。
该报告提供了欧洲止血的流行趋势分析仪市场以及与市场增长相关的驱动因素和限制因素。据估计,该市场的增长是心血管疾病数量的增加和老年人口的增加是推动市场增长的关键因素。然而,由于全自动止血分析仪的成本较高,预计该市场在预测期内增长缓慢。
继亚洲之后,欧洲地区受疫情影响较大COVID-19 大流行。意大利、西班牙、英国、德国、法国等国家以及俄罗斯、瑞士等其他欧洲国家受到严重影响。由于该地区 COVID-19 病例呈指数级增长,欧洲经济受到严重影响。西班牙、意大利、德国、法国和英国是受影响最严重的欧洲国家,死亡人数也很高。根据《国际卫生条例》,世界卫生组织已将当前冠状病毒(COVID-19)疫情列为国际关注的突发公共卫生事件。与新冠病毒感染和特定疫苗相关的血栓是最值得关注的问题。然而,因接种新冠疫苗而导致的血液凝固的发生率很少,该地区的监管机构已证实正在对其进行严密监控。因此,预计未来几年市场增长可能会放缓。
市场概况与动态
欧洲止血欧洲分析仪市场预计将从2021年的10.575亿美元增长到2028年的19.702亿美元;预计 2021 年至 2028 年复合年增长率为 9.3%。自动化正在成为一种尽量减少人类参与实验室流程的方法。借助专用工作站和系统软件,常规实验室程序的自动化有助于提高效率并减少人为错误。实验室越来越多地采用实验室信息管理系统 (LIMS) 和其他自动化工具来保持严格的法规遵从性、提高效率和生产力并增强数据安全性和完整性。根据发表在《实验室自动化杂志》上的研究,全自动、半自动和手动操作的错误频率分别为 1-5%、1-10% 和 10-30%。此外,实验室系统生成的大量数据引发了对有效数据处理、分析和共享方法的需求,从而凸显了对 LIMS 等高效且具有成本效益的解决方案的需求。
< p>从产品类型来看,实验室分析仪细分市场占比最大2020年欧洲止血分析仪市场份额。在测试方面,d-二聚体测试领域占据2020年欧洲止血分析仪市场的最大份额。在最终用户方面, 2020年,医院/诊所细分市场占据欧洲止血分析仪市场的最大份额。
主要来源和上市公司
准备本欧洲止血分析仪市场报告时提到的一些主要一手和二手来源是公司网站、年度报告、财务报告、国家政府文件、和统计数据库等。报告中列出的主要公司有:Siemens Healthineers AG、Abbott、Sysmex Corporation、Nihon Kohden Corporation、THERMO FISHER SCIENTIFIC INC.、HOFFMANN-LA ROCHE LTD。 ,仪器实验室公司。
购买报告的理由
欧洲止血分析仪市场细分
按产品类型
通过测试
最终用户 span>
按国家/地区< /p>
提及的公司 -
Strategic insights for Europe Hemostasis Analyzers involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 1,057.50 Million |
Market Size by 2028 | US$ 1,970.20 Million |
Global CAGR (2021 - 2028) | 9.3% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 产品类型
|
Regions and Countries Covered | 欧洲
|
Market leaders and key company profiles |
The regional scope of Europe Hemostasis Analyzers refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Hemostasis Analyzers Market is valued at US$ 1,057.50 Million in 2021, it is projected to reach US$ 1,970.20 Million by 2028.
As per our report Europe Hemostasis Analyzers Market, the market size is valued at US$ 1,057.50 Million in 2021, projecting it to reach US$ 1,970.20 Million by 2028. This translates to a CAGR of approximately 9.3% during the forecast period.
The Europe Hemostasis Analyzers Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Hemostasis Analyzers Market report:
The Europe Hemostasis Analyzers Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Hemostasis Analyzers Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Hemostasis Analyzers Market value chain can benefit from the information contained in a comprehensive market report.